Six of the 13 assessed adult cases and 6 of the 15 pediatric cases showed nuclear p53 immunostaining in greater than 25% of tumor cells, acknowledging that firm cut-off levels for what percentage labeling index for nuclear p53 protein parallels TP53 mutation have not been established. The gene discussed is TP53; the disease is neoplasm.